Britta Lamottke

841 total citations
8 papers, 420 citations indexed

About

Britta Lamottke is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Britta Lamottke has authored 8 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Britta Lamottke's work include Multiple Myeloma Research and Treatments (3 papers), Signaling Pathways in Disease (2 papers) and Peptidase Inhibition and Analysis (2 papers). Britta Lamottke is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Signaling Pathways in Disease (2 papers) and Peptidase Inhibition and Analysis (2 papers). Britta Lamottke collaborates with scholars based in Germany, United States and Switzerland. Britta Lamottke's co-authors include Ulrike Heider, Orhan Sezer, Ivana von Metzler, Jessica Rademacher, Maren Mieth, Chalid Assaf, Jan Sterz, Martin Kaiser, Evangelos Terpos and Christian Jakob and has published in prestigious journals such as Experimental Cell Research, Expert Opinion on Investigational Drugs and European Journal Of Haematology.

In The Last Decade

Britta Lamottke

8 papers receiving 411 citations

Peers

Britta Lamottke

MB

ONCOL

PFM

HEMAT

IMMUN

H. Eugene Liu Taiwan

Alexandra Moros Spain

Mio Yamamoto‐Sugitani Japan

Laurianne Scourzic France

Ashwini Yenamandra United States

Jennifer Kimberly Lue United States

Dejan Radeski Australia

Andrew Belch Canada

Kris Jacobs Belgium

H. Eugene Liu Taiwan

Britta Lamottke

260 ×0.9

MB

124 ×0.8

ONCOL

48 ×0.5

PFM

70 ×0.8

HEMAT

48 ×0.9

IMMUN

Citations per year, relative to Britta Lamottke Britta Lamottke (= 1×) peers H. Eugene Liu

Countries citing papers authored by Britta Lamottke

Since Specialization

Citations

This map shows the geographic impact of Britta Lamottke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Lamottke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Lamottke more than expected).

Fields of papers citing papers by Britta Lamottke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Lamottke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Lamottke. The network helps show where Britta Lamottke may publish in the future.

Co-authorship network of co-authors of Britta Lamottke

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Lamottke. A scholar is included among the top collaborators of Britta Lamottke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Lamottke. Britta Lamottke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Tischer‐Zimmermann, Sabine, Hans‐Gert Heuft, Christoph Priesner, et al.. (2019). Transfer of Hexon‐ and Penton‐selected adenovirus‐specific T cells for refractory adenovirus infection after haploidentical stem cell transplantation. Transplant Infectious Disease. 22(1). e13201–e13201. 4 indexed citations

2.

Wimmer, Katharina, Andreas Beilken, R. Nustede, et al.. (2016). A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency. Familial Cancer. 16(1). 67–71. 50 indexed citations

3.

Lamottke, Britta, Martin Kaiser, Maren Mieth, et al.. (2012). The novel, orally bioavailable HSP90 inhibitor NVP‐HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases. European Journal Of Haematology. 88(5). 406–415. 24 indexed citations

4.

Heider, Ulrike, Jessica Rademacher, Britta Lamottke, et al.. (2009). Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma. European Journal Of Haematology. 82(6). 440–449. 141 indexed citations

5.

Kaiser, Martin, Britta Lamottke, Maren Mieth, et al.. (2009). Synergistic action of the novel HSP90 inhibitor NVP‐AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma. European Journal Of Haematology. 84(4). 337–344. 36 indexed citations

6.

Metzler, Ivana von, Ulrike Heider, Maren Mieth, et al.. (2009). Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma. Experimental Cell Research. 315(14). 2471–2478. 10 indexed citations

7.

Sterz, Jan, Ivana von Metzler, Britta Lamottke, et al.. (2008). The potential of proteasome inhibitors in cancer therapy. Expert Opinion on Investigational Drugs. 17(6). 879–895. 102 indexed citations

8.

Heider, Ulrike, Martin Kaiser, Maren Mieth, et al.. (2008). Serum concentrations of DKK‐1 decrease in patients with multiple myeloma responding to anti‐myeloma treatment. European Journal Of Haematology. 82(1). 31–38. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact